M&A Drives Biotech Surge in 2025: What Lies Ahead?
Small and mid-cap biotech stocks experienced a significant rebound in early 2025, driven largely by a surge in mergers and acquisitions (M&A). According to Dr. Terry Smith, Director of Life…
Breaking News & Top Stories
Small and mid-cap biotech stocks experienced a significant rebound in early 2025, driven largely by a surge in mergers and acquisitions (M&A). According to Dr. Terry Smith, Director of Life…